CancerRadarCancerRadar
RadiopharmaceuticalFDA-approvedSecond-line

Radium Ra 223 dichloride

Generic name: radium Ra 223 dichloride

How it works

Delivers targeted radiation to prostate cancer cells, killing them through radiation damage.

Cancer types

Prostate Cancer

Efficacy

In clinical trials, radium Ra 223 dichloride significantly improved overall survival in patients with castration-resistant prostate cancer.

Side effects

Severe

This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.

This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.